Here is an interesting article in Forbes Magazine. It is talking about a recent study done in the UK.
It states “Mice with pancreatic cancer treated with a combination of cannabidiol (CBD) and chemotherapy survived nearly three times longer than those treated with chemotherapy alone, according to a new study that spotlights the potential for human treatment.”
“Cannabidiol is already approved for use in clinics [in the UK], which means we can quickly go on to test this in human clinical trials,” said lead researcher Marco Falasca from Queen Mary University of London.
This is a very promising study. It is showing the progress that is being made to treat all kinds of ailments from Migraine headaches to Cancer. Obviously the testing for human trials will take more time.
Lets hope they continue to explore and validate the test results in a human study soon.
If you are interested in learning more about CBD please check out my other articles.
For information on the CBD Oil we use daily and recommend to others click HERE.
Discover more about Network Marketing and how it can help you!
Thanks for reading!
Mark Balderrama
